ZOLL announces definitive agreement to acquire Advanced Circulatory Systems, Inc.

Published on:

December 22, 2014—Chelmsford, Mass.—ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, today announced that it has reached a definitive agreement to acquire Advanced Circulatory Systems, Inc., based in Roseville, Minn., which develops technologies to non-invasively increase circulation.

Founded in 1997, Advanced Circulatory Systems’ innovative technologies use the body’s own mechanisms to enhance circulation without the use of pharmaceutical or other agents.  Multiple studies have demonstrated how Advanced Circulatory Systems’ technologies may assist in increasing circulation, cardiac output, and systolic blood pressure.

Advanced Circulatory Systems’ novel Intrathoracic Pressure Regulation (IPR) therapy platform has far-reaching implications for multiple medical conditions. This non-invasive therapy can potentially protect the heart, brain, and other vital organs when blood flow is compromised, giving rescuers, clinicians, and caregivers the potential to return patients to a full life after critical medical emergencies.

“The acquisition of Advanced Circulatory Systems will broaden ZOLL’s product offerings with additional technologies designed to improve outcomes from cardiac arrest and other critical conditions," said Jonathan A. Rennert, President of ZOLL. “This acquisition further demonstrates ZOLL’s commitment to offering the most comprehensive portfolio of products for acute events where rapid medical intervention is needed.”

“Becoming part of ZOLL provides Advanced Circulatory Systems with an increased infrastructure of clinical and commercial resources that will enable our technologies to reach a greater number of clinicians and positively affect more patients’ lives,” said Mike Black, CEO of Advanced Circulatory Systems. “The acquisition gives Advanced Circulatory Systems the opportunity to become a part of a company with a long history of improving resuscitation science.”

ZOLL anticipates the transaction will close in early 2015. Advanced Circulatory Systems will continue to operate out of Minnesota as a part of ZOLL’s Core Products division.

Related Content

Concomitant ablation surgery during heart operations boosts long-term survival
Cardiologist explores why colchicine failed to help heart attack patients
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Most heart failure patients miss out on guideline-recommended palliative care
Cardiologist behind EARLY TAVR explains how proactive treatment improves patient outcomes
FDA approves Medtronic’s new all-in-one mapping and ablation system for AFib

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."